Search research articles
Contact Us
Filters
Showing results (1-10 of 115) with videos related to
Page
of 12
Sort By:
Cell Chemical Biology
|
October 22, 2019
Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation
Tinghu Zhang, John M Hatcher, Mingxing Teng, et al.
Plos One
|
July 21, 2012
BAY61-3606 affects the viability of colon cancer cells in a genotype-directed manner
Ken S Lau, Tinghu Zhang, Krystle R Kendall, et al.
Molecular Systems Biology
|
March 28, 2015
Systematic analysis of BRAF(V600E) melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis
Mohammad Fallahi-Sichani, Nathan J Moerke, Mario Niepel, et al.
The Biochemical Journal
|
May 18, 2017
The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists
Stefan Vollmer, Sam Strickson, Tinghu Zhang, et al.
Chemistry & Biology
|
February 27, 2013
Developing irreversible inhibitors of the protein kinase cysteinome
Qingsong Liu, Yogesh Sabnis, Zheng Zhao, et al.
Plos One
|
March 2, 2016
Inhibition of IKKα by BAY61-3606 Reveals IKKα-Dependent Histone H3 Phosphorylation in Human Cytomegalovirus Infected Cells
Catherine M K Ho, I'ah Z Donovan-Banfield, Li Tan, et al.
Angewandte Chemie (International Ed. in English)
|
February 26, 2019
Development of Dual and Selective Degraders of Cyclin-Dependent Kinases 4 and 6
Baishan Jiang, Eric S Wang, Katherine A Donovan, et al.
RSC Medicinal Chemistry
|
August 30, 2021
Selective degradation-inducing probes for studying cereblon (CRBN) biology
Chelsea E Powell, Guangyan Du, Jonathan W Bushman, et al.
RSC Chemical Biology
|
August 30, 2021
Fragment-based covalent ligand discovery
Wenchao Lu, Milka Kostic, Tinghu Zhang, et al.
RSC Chemical Biology
|
August 30, 2021
Correction: Fragment-based covalent ligand discovery
Wenchao Lu, Milka Kostic, Tinghu Zhang, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 115) with videos related to
Sort By:
Page
of 12
Cell Chemical Biology
|
October 22, 2019
Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation
Tinghu Zhang, John M Hatcher, Mingxing Teng, et al.
Plos One
|
July 21, 2012
BAY61-3606 affects the viability of colon cancer cells in a genotype-directed manner
Ken S Lau, Tinghu Zhang, Krystle R Kendall, et al.
Molecular Systems Biology
|
March 28, 2015
Systematic analysis of BRAF(V600E) melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis
Mohammad Fallahi-Sichani, Nathan J Moerke, Mario Niepel, et al.
The Biochemical Journal
|
May 18, 2017
The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists
Stefan Vollmer, Sam Strickson, Tinghu Zhang, et al.
Chemistry & Biology
|
February 27, 2013
Developing irreversible inhibitors of the protein kinase cysteinome
Qingsong Liu, Yogesh Sabnis, Zheng Zhao, et al.
Plos One
|
March 2, 2016
Inhibition of IKKα by BAY61-3606 Reveals IKKα-Dependent Histone H3 Phosphorylation in Human Cytomegalovirus Infected Cells
Catherine M K Ho, I'ah Z Donovan-Banfield, Li Tan, et al.
Angewandte Chemie (International Ed. in English)
|
February 26, 2019
Development of Dual and Selective Degraders of Cyclin-Dependent Kinases 4 and 6
Baishan Jiang, Eric S Wang, Katherine A Donovan, et al.
RSC Medicinal Chemistry
|
August 30, 2021
Selective degradation-inducing probes for studying cereblon (CRBN) biology
Chelsea E Powell, Guangyan Du, Jonathan W Bushman, et al.
RSC Chemical Biology
|
August 30, 2021
Fragment-based covalent ligand discovery
Wenchao Lu, Milka Kostic, Tinghu Zhang, et al.
RSC Chemical Biology
|
August 30, 2021
Correction: Fragment-based covalent ligand discovery
Wenchao Lu, Milka Kostic, Tinghu Zhang, et al.
Page
of 12